Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

"Chronic Urticaria Or Hives - Pipeline Review, H2 2013" is now available at Fast Market Research


Print article Print article
2014-01-27 11:04:59 - Recently published research from Global Markets Direct, "Chronic Urticaria Or Hives - Pipeline Review, H2 2013", is now available at Fast Market Research

Global Markets Direct's, 'Chronic Urticaria Or Hives - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chronic Urticaria Or Hives, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Urticaria Or Hives. Chronic Urticaria Or Hives - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- www.fastmr.com/prod/769218_chronic_urticaria_or_hives_pipeline_r ..

Note*: Certain sections in the report may be

removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Chronic Urticaria Or Hives.
* A review of the Chronic Urticaria Or Hives products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Chronic Urticaria Or Hives pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Chronic Urticaria Or Hives.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Chronic Urticaria Or Hives pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Genentech, Inc., Merck & Co., Inc., Biofrontera AG, Sun Pharmaceutical Industries Limited, FAES Farma SA, AEterna Zentaris Inc., JDP Therapeutics Inc.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chronic Urticaria Or Hives Overview
Therapeutics Development
Pipeline Products for Chronic Urticaria Or Hives - Overview
Pipeline Products for Chronic Urticaria Or Hives - Comparative Analysis
Chronic Urticaria Or Hives - Therapeutics under Development by Companies
Chronic Urticaria Or Hives - Therapeutics under Investigation by Universities/Institutes
Chronic Urticaria Or Hives - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Unknown Stage Products
Chronic Urticaria Or Hives - Products under Development by Companies
Chronic Urticaria Or Hives - Products under Investigation by Universities/Institutes
Chronic Urticaria Or Hives - Companies Involved in Therapeutics Development
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Merck & Co., Inc.
Biofrontera AG
Sun Pharmaceutical Industries Limited
FAES Farma SA
AEterna Zentaris Inc.
JDP Therapeutics Inc.
Chronic Urticaria Or Hives - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Assessment by Therapeutic Class
Drug Profiles
omalizumab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
desloratadine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
JDP-205 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BF-Derm-1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
quilizumab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SUN-1334 H - Drug Profile
Product Description
Mechanism of Action
R&D Progress
immune globulin intravenous (human) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
miltefosine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
abatacept - Drug Profile
Product Description
Mechanism of Action
R&D Progress
bilastine - Drug Profile
Product Description
Mechanism of Action
R&D Progress

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=769218&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com